BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Montelukast Sodium Oral Soluble Film regulatory update

MonoSol Rx said FDA has agreed with its plan to submit an NDA for Montelukast Sodium Oral Soluble Film (OSF) to treat asthma and allergic rhinitis, and to...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >